| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.76B | +16.3% |
| Cost of Revenue | $947.9M | +9.3% |
| Gross Profit | $812.1M | +25.6% |
| R&D Expense | $123.0M | +9.8% |
| SG&A Expense | $366.0M | +39.1% |
| Operating Income | $104.1M | -21.8% |
| Interest Expense | $40.6M | +12.5% |
| Pre-tax Income | $37.6M | -60.8% |
| Income Tax | $19.5M | -52.7% |
| Net Income | $18.1M | -67.0% |
| EPS (Basic) | $0.11 | -68.6% |
| EPS (Diluted) | $0.11 | -68.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $579.7M | +1.6% |
| Accounts Receivable | $264.8M | +15.7% |
| Current Assets | $5.98B | +0.5% |
| Total Assets | $9.12B | +1.2% |
| Current Liabilities | $5.31B | -0.4% |
| Long-term Debt | $1.21B | -0.1% |
| Total Liabilities | $6.57B | -0.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $281.1M | +28.1% |
| Investing Cash Flow | -$471.9M | -132.7% |
| Financing Cash Flow | $59.6M | -75.4% |
| Stockholders' Equity |
| $2.55B |
| +6.2% |